Icosavax, Inc. Employee Directory
Biotechnology ResearchWashington, United States11-50 Employees
Icosavax, Inc. is a biotechnology company focused on developing safe and effective vaccines against infectious diseases with unmet medical needs, aiming to reduce healthcare costs. The company was established on computationally designed virus-like particle technology licensed exclusively from the Institute for Protein Design at the University of Washington. Icosavax is based in Seattle, Washington, and is a member of the AstraZeneca Group. As a smaller biotechnology company, it operates within the infectious disease vaccine landscape, pursuing products intended to address significant health challenges. Its work centers on applying the licensed technology to vaccine candidates for infectious disease indications with potential healthcare savings. The company’s location and AstraZeneca affiliation place it within the broader pharmaceutical ecosystem of the Pacific Northwest.